Evolution of the Average Target: GlaxoSmithKline Pakistan Limited

Evolution of the Average Target - GlaxoSmithKline Pakistan Limited

Evolution of the Target Price: GlaxoSmithKline Pakistan Limited

Evolution of the Target Price - GlaxoSmithKline Pakistan Limited

Changes in Analyst Recommendations: GlaxoSmithKline Pakistan Limited

0423e8fa490b92ee9e4.km2v3MfTyo3JnROFOwhc4YPKBWPS2kI1cPPifwYsaKM.y1XwiaCSkOGcrGn0f19qs66hUSWw9wRzJYHaKUd5MpLjGM62qqOv5IjNVg~07dbff49ca238cfa45a3857dfc79d899

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +49.42%
+1.47%
-0.49%
+5.7%
-1.34%
+9.1%
-5.5%
+16.05%
-7.63%
+2.28%
Average +6.91%
Weighted average by Cap. +2.06%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
341.49PKR
Average target price
510.00PKR
Spread / Average Target
+49.35%
High Price Target
510.00PKR
Spread / Highest target
+49.35%
Low Price Target
510.00PKR
Spread / Lowest Target
+49.35%

Analyst Consensus Detail

Analyst consensus - GlaxoSmithKline Pakistan Limited

Consensus revision (last 18 months)

Consensus revision (last 18 months) - GlaxoSmithKline Pakistan Limited
  1. Stock Market
  2. Stocks
  3. GLAXO Stock
  4. Consensus GlaxoSmithKline Pakistan Limited